TamarHamoshTaddeiMDFAASLD, AGAF

Hepatology & Liver Transplantation

Professor of Medicine, Section of Digestive Diseases Associate Program Director, MD/PhD Program Director, Liver Cancer Program, VA Connecticut Healthcare System

Join to view full profile

Dr. Taddei is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Taddei's full profile

Already have an account?

Office
950 Campbell Ave
Veterans Administration
West Haven, CT 06516
Phone+1 203-932-5711

Fax+1 203-937-3873

Education & Training

Yale-New Haven Medical CenterFellowship, Gastroenterology, 2004 - 2007
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2000 - 2004
Georgetown University School of MedicineClass of 2000

Certifications & Licensure

CT State Medical License 2007 - 2025
VA State Medical License 2000 - 2022
DC State Medical License 2003 - 2004
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

Most Compassionate Doctor American Registry

Clinical Trials

The Effect of Sorafenib on Portal Pressure Start of enrollment: 2011 Aug 01
Completed
Phase 2
Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis Start of enrollment: 2020 Oct 02
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

4 citations
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.
Keyur Patel, Sumeet K Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H Leung
Hepatology. 2025-01-01
10 citations
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis.
Richard K Sterling, Keyur Patel, Andres Duarte-Rojo, Sumeet K Asrani, Mouaz Alsawas
Hepatology. 2025-01-01
Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death.
Philip Vutien, Abbey Barnard Giustini, Nicole J Kim, Andrew M Moon, Chun-Nan Hsu
Hepatology. 2024-12-17

Press Mentions

Listen to "Liver Cancer Screening: A New Tool for Improved-DetectionNovember 8th, 2024
Liver Cancer Screening Post-Hep C Cure Improves SurvivalSeptember 10th, 2024
The VA Launches Largest-Ever Trial on Screening Methods for Liver CancerDecember 21st, 2022
Join now to see all